Literature DB >> 16157821

Evaluation of moxifloxacin, ciprofloxacin, gatifloxacin, ofloxacin, and levofloxacin concentrations in human conjunctival tissue.

Rudolph S Wagner, Mark B Abelson, Aron Shapiro, Gail Torkildsen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16157821     DOI: 10.1001/archopht.123.9.1282

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


× No keyword cloud information.
  7 in total

1.  The role of topical moxifloxacin, a new antibacterial in Europe, in the treatment of bacterial conjunctivitis.

Authors:  Jose Benitez-Del-Castillo; Yves Verboven; David Stroman; Laurent Kodjikian
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

Review 2.  Moxifloxacin 0.5% ophthalmic solution: in bacterial conjunctivitis.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2011-01-01       Impact factor: 9.546

3.  A comparison of moxifloxacin and levofloxacin topical prophylaxis in a fluoroquinolone-resistant Staphylococcus aureus rabbit model.

Authors:  Regis P Kowalski; Eric G Romanowski; Francis S Mah; Hiroshi Sasaki; Masamichi Fukuda; Y J Gordon
Journal:  Jpn J Ophthalmol       Date:  2008-07-27       Impact factor: 2.447

4.  Concentrations of besifloxacin, gatifloxacin, and moxifloxacin in human conjunctiva after topical ocular administration.

Authors:  Gail Torkildsen; Joel W Proksch; Aron Shapiro; Stephanie K Lynch; Timothy L Comstock
Journal:  Clin Ophthalmol       Date:  2010-04-26

Review 5.  Levofloxacin 0.5% ophthalmic solution: a review of its use in the treatment of external ocular infections and in intraocular surgery.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2009-06-18       Impact factor: 9.546

6.  New treatments for bacterial keratitis.

Authors:  Raymond L M Wong; R A Gangwani; Lester W H Yu; Jimmy S M Lai
Journal:  J Ophthalmol       Date:  2012-09-06       Impact factor: 1.909

7.  Clinical use of gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis.

Authors:  Lorenzo J Cervantes; Francis S Mah
Journal:  Clin Ophthalmol       Date:  2011-04-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.